The NVGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NVGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NVGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NVGN Detailed Price Forecast - CNN Money||View NVGN Detailed Summary - Google Finance|
|View NVGN Detailed Summary - Yahoo! Finance||View NVGN Stock Research & Analysis - Zacks.com|
|View NVGN Trends & Analysis - Trade-Ideas||View NVGN Major Holders - Barrons|
|View NVGN Call Transcripts - NASDAQ||View NVGN Breaking News & Analysis - Seeking Alpha|
|View NVGN Annual Report - CompanySpotlight.com||View NVGN OTC Short Report - OTCShortReport.com|
|View NVGN Fundamentals - TradeKing||View NVGN SEC Filings - Bar Chart|
|View Historical Prices for NVGN - The WSJ||View Performance/Total Return for NVGN - Morningstar|
|View the Analyst Estimates for NVGN - MarketWatch||View the Earnings History for NVGN - CNBC|
|View the NVGN Earnings - StockMarketWatch||View NVGN Buy or Sell Recommendations - MacroAxis|
|View the NVGN Bullish Patterns - American Bulls||View NVGN Short Pain Metrics - ShortPainBot.com|
|View NVGN Stock Mentions - StockTwits||View NVGN Stock Mentions - PennyStockTweets|
|View NVGN Stock Mentions - Twitter||View NVGN Investment Forum News - Investor Hub|
|View NVGN Stock Mentions - Yahoo! Message Board||View NVGN Stock Mentions - Seeking Alpha|
|View Insider Transactions for NVGN - SECform4.com||View Insider Transactions for NVGN - Insider Cow|
|View NVGN Major Holdings Summary - CNBC||View Insider Disclosure for NVGN - OTC Markets|
|View Insider Transactions for NVGN - Yahoo! Finance||View Institutional Holdings for NVGN - NASDAQ|
|View NVGN Stock Insight & Charts - FinViz.com||View NVGN Investment Charts - StockCharts.com|
|View NVGN Stock Overview & Charts - BarChart||View NVGN User Generated Charts - Trading View|
Edison Issues ADR Update on Novogen (NVGN)
Posted on Monday September 11, 2017
LONDON, UK / ACCESSWIRE / September 11, 2017 / Novogen (NASDAQ: NVGN) is on track to commence a Phase II trial of GDC-0084 in glioblastoma in Q4 CY17, in line with previous guidance. It plans to meet with ...
Australian cancer specialists may hold key to next advancement in ovarian cancer treatment
Posted on Wednesday August 30, 2017
SYDNEY, Aug. 30, 2017 /PRNewswire/ -- Three leading Australian cancer treatment centres are at the forefront of a drug trial that could see the next major advancement in ovarian cancer therapy. Flinders Medical Centre in South Australia and Westmead Hospital in Sydney are also participating, along with leading US hospitals Peggy and Charles Stephenson Cancer Centre, and Mary Crowley Cancer Research Centre. "We've seen massive developments in other types of cancer but ovarian cancer has remained a challenge and, despite it being an unforgiving disease for women, treatment options have fallen behind as money and research are focused elsewhere," Associate Professor Coward said.
GDC-0084 Progress Update: On Track for Phase II Commencement in 2017
Posted on Tuesday August 22, 2017
NASDAQ: NVGN), an Australian oncology drug development company, is pleased to provide an update to investors on progress with its clinical-stage drug development candidate, GDC-0084. GDC-0084 was in-licensed from Genentech, Inc in October 2016, after completion of a phase I clinical trial in advanced glioma.
Board Review of Business Operations and Governance
Posted on Monday August 14, 2017
NASDAQ: NVGN), an Australian oncology drug development company, is pleased to provide an update to investors on a review of business operations recently completed by the Board and management team. The review was initiated following appointment of Iain Ross as Chairman on 8 June 2017, and has involved an extensive process of consultation with shareholders and investors.